Note: Descriptions are shown in the official language in which they were submitted.
CA 02133436 2003-08-08
WO 93/20208 PCTtUS93/03251
METHODS FOR PRODUCING
EG III CELLULASE, XYLANASE OR
A MIXTURE THEREOF USING POLYETHYLENE GLYCOL
BACRGROIIrID OF THE INVENTION
1. Field of the Invention
The present invention is directed to methods for
producing a polyethylene glycol solution containing
substantially pure EG III cellulase component. In
particular, the methods of the present invention are
directed in part, to the separation of EG III cellulase
component from an aqueous mixture of cellulase proteins
containing EG III by the addition of a specified
polyethylene glycol to the aqueous mixture to create a
two-phase system containing an EG III-rich polyethylene
glycol phase and an EG III-poor aqueous phase and
separating the EG III-rich phase. The present
invention.is also directed in part to methods for
preparing substantially pure EG III cellulase component
by fractionation or by a combination of the above two
methods. The present invention is also directed in
part, to the enrichment of a xylanase polyethylene
glycol phase from an aqueous mixture of cellulase
proteins also containing xylanase.
2. State of the Art
Cellulases are known in the art as enzymes that
hydrolyze cellulose (B-1,4-glucan linkages) thereby
resulting in the formation of glucose, cellobiose,
WO 93/20208 2133436 pCT/US93/0325;'!,-' .:
_ 2 _
cellooligosaccharides, and the like.. While cellulases
are produced (expressed) in fungi, bacteria and the
like, cellulase produced by certain fungi and, in particular by the fungus
class Trichoderma spU.
(especially Iricr,hoderma reesei), have been given the
most attention because a complete cellulase system
capable of degrading crystalline forms of cellulose is
readily produced in large quantities via fermentation
procedures.
In regard to the above, Schulein, "Methods in
Enzymology", 160, 25, pages 234 et seq. (1988),
disclose that complete fungal cellulase systems
comprise several different enzyme classifications
including those identified as exo-cellobiohydrolases
(EC 3.2.1.91) ("CBH"), endoglucanases (EC 3.2.1.4)
(õEG"), and B-glucosidases (EC 3.2.1.21) ("BG"). The
fungal cellulase classifications of CBH, EG and BG can
be further expanded to include multiple components
within each classification. For example, multiple CBHs
and EGs have been isolated from a variety of fungal
sources.
The complete cellulase system comprising CBH, EG
and BG components is required to efficiently convert
crystalline cellulose to glucose. Isolated components
are far less effective, if at all, in hydrolyzing
crystalline cellulose. Moreover, a synergistic
relationship is observed between the cellulase
components particularly if they are of different
classification.
On theFother hand, cellulases and components
thereof, used either singularly or in combination, are
also known in the art to be useful in detergent
compositions. For example, endoglucanase components of
fungal cellulases have been used for the purposes of
enhancing the cleaning ability of detergent
CA 02133436 2003-08-08
WO 93/20208 PCT/US93/03251
- 3 -
compositions, for use as a softening agent, and for use
in improving the feel of cotton fabrics, and the like.
However, there is a problem with using the EG I and EG
II components derived from Trichoderma Spp. and
especially Trichoderma reesei in detergent
compositions. Specifically, such components have their
maximal activity at acidic pHs whereas most laundry
detergent compositions are formulated for use at
neutral or alkaline (pH >7 to about 10) conditions.
While it is disclosed in iW0 92/06210
that the use of one or more acidic endoglucanase
components of Trichoderma reesei in detergent
compositions will provide improvements in softening,
color retention/restoration and feel to cotton-
containing fabrics even when treated under alkaline
conditions, it is disclosed in U.S. Patent No.
5,290,474 that the EG III component of Trichoderma
SDD. provides for superior and unexpected advantages in
detergent compositions as compared to the EG I and EG
II components of Trichoderma rgesei.
Specifically, the EG III cellulase component has
been found to possess significant enzymatic activity
under alkaline conditions and is particularly suited
for use in laundry conditions where a neutral or
alkaline detergent wash medium is employed.
In addition to its use in laundry detergents, the
substantially pure EG III cellulase component described
herein can additionally be used in a pre-washing step
in the appropriate solution at an intermediate pH where
sufficient activity exists to provide desired
improvements in color retention/restoration, softening
and feel as disclosed in U.S. Patent 5,290,474.
CA 02133436 2003-08-08
WO 93/20208 PCT/US93/03251
- 4 -
Also, it is contemplated that the substantially
pure EG III cellulase component described herein can be
used in home use as a stand alone composition suitable
for restoring color to faded fabrics (see, for example,
U.S. Patent No. 4,738,682), as well as used in a
spot-remover.
Additionally, it is further contemplated that the
high activity under neutral to alkaline conditions of
the EG III cellulase component would be beneficial in
textile processes for treating cotton-containing
fabrics (see U.S. Patent No. 5,246,853 and WO 92/17574)
as well as in silage and/or composting processes.
In contrast to the above, this invention is
directed to efficient processes for the separation and
purification of.the EG III cellulase component from
aqueous enzyme mixtures, particularly from a complete
fungal cellulase composition and particularly for
commercial scale production of the EG III cellulase
component.
BVMMARY OF T8E INVENTION
Specifically, the present invention is directed to
methods for producing a polyethylene glycol solution
containing substantially pure EG III cellulase
component from an aqueous mixture containing cellulase
proteins including EG III cellulase component.
Accordingly, in one of its method aspects, the present
invention is directed to a method for selectively
recovering EG III from an aqueous mixture containing
cellulase proteins including EG III cellulase, which
WO 93/20208 ~3 113 b PCT/US93/03251
- 5 -
method comprises the addition to the aqueous mixture of
an effective amount of polyethylene glycol (PEG) in the
presence of a inorganic salt. The mixture forms a.two
phase liquid mixture containing an EG III-rich
polyethylene glycol phase and an EG III-poor aqueous
phase. In this embodiment, the EG III-rich phase is
substantially free of other cellulase proteins and is
then separated.
The methods of the present invention are also
directed in part, to the isolation of substantially
pure xylanase from an aqueous mixture of cellulase
proteins also containing xylanase by addition to the
aqueous mixture of an effective amount of polyethylene
glycol in the presence of an inorganic salt. When the
aqueous mixture also contains EG III, the recovered
polyethylene glycol phase contains both EG III and
xylanase.
In another method, the present invention is
directed to selectively recovering EG III cellulase
from an aqueous cellulase protein mixture including EG
III, which method comprises applying the aqueous
mixture to an anion exchange column. The protein
fraction not bound to the anion exchange column
contains.the EG III component. This fraction is then
applied to a cation exchange column, which binds the EG
III cellulase, which is later eluted from the resin
with a salt solution.
A third preferred method of this invention is a
qombination of the above two methods in either order.
The aqueous cellulase protein mixture can be a
whole cell extract or, more preferably, a whole
cellulase composition from a wild-type Trichoderma sPp=
strain, a genetically modified Trichoderma spP= strain
or any other aqueous mixture containing cellulase
W 93/20208 2133436 PC I'/US93/0325? -- 6 -
proteins including EG III which is compatible with the
methods of this invention.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 illustrates the RBB-CMC activity profile
over a pH range at 40 C for an EG enriched fungal
cellulase composition derived from a strain of
Trjchode,Ma reesei transformed so as to be incapable of
expressing CBH I and CBH II; as well as the activity
profile of an enriched EG III cellulase composition
derived from Trichoderma reesei over a pH range at
40 C.
FIG. 2 is an isoelectric focusing gel which, in
Lane 1, displays the proteins expressed by a wild type
Trichoderma reesei; in Lane 2 displays the proteins
expressed by a strain of Trichoderana reesgi transformed
so as to be incapable of expressing EG I and EG II
components; and in Lane 3 displays the proteins found
in substantially pure EG III cellulase similar to that
obtained by the method of Example 1. The right hand
margiri of this Figure is marked so as to identify the
bands attributable to CBH I, CBH II, EG I, EG II, EG
III and xylanase.
FIG. 3 is the amino acid sequence obtained from
two fragments of EG III.
FIG. 4 is an outline of the construction of
paCBHIp_yr4.
FIG. 5 illustrates deletion of the T. reesei gene
by integration of the larger EcoRI fragment from
WO 93/20208 PCT/US93/03251
- 7 - i
pACBHIpvr4 at the cbhl locus on one of the T. reesei
chromosomes.
FIG. 6 is an autoradiograph of DNA from T. reesei
strain GC69.transformed with EcoRI digested pGCBHIpyr4
after Southern blot analysis using a 32P-labelled
pdCBHIvvr4 as the probe. The sizes of molecular weight
markers are shown in kilobase pairs to theleft of the
Figure.
FIG. 7 is an autoradiograph of DNA from a T.
reesei strain.GC69 transformed with EcoRI digested
pACBHIPvr.4 using a 32P-labelled pIntCBHI as the probe.
The sizes of molecular weight markers are shown in
kilobase pairs to the left of the Figure.
FIG. 8 is an isoelectric focusing gel displaying
the proteins secreted by the wild type and by
transformed strains of T. reesei. Specifically, in
FIG. 8, Lane A of the isoelectric focusing gel employs
partially.purified CBHI from T. reesei; Lane B employs
a wild type T. reesei : Lane C employs protein from a
T. reesei strain with the ebhl gene deleted; and Lane D
employs proteinfrom aT_. Xeenei strain with the cbhl
and cbh2 genes deleted. In FIG. 8, the right hand side
of the figure is marked to indicate the location of the
single proteins found in one or more of the secreted
proteins. Specifically, BG refers to the
,.; g;lucosidase, El, refers to endoglucanase I, E2 refers to
endoglucanase II, E3 refers to endoglucanase III, Cl
refers to exo-cellobiohydrolase I and C2 refers to exo-
cellobiohydrolase II.
FIG. 9A is a representation of the T. reesei cbh2
locus, cloned as a 4.1 kb EcoRI fragment on genomic DNA
WO 93/20208 2133.436 PCI'/US93/03257--
- 8 -
and FIG. 9B is a representation of the cbh2 gene
deletion vector pP CBHII.
=M
FIG. 10 is an autoradiograph of DNA from T. reesei
strain P37P CBH?Pyr'26 transformed with EcoRI digested
pPBCBHII after Southern blot analysis using a 32P
labelled pP CBHII as the probe. The sizes of molecular
weight markers are shown in kilobase pairs to the left
of the Figure.
FIG. 11 is an outline of the construction of
p1.1EGIpyrG-3.
FIG. 12 illustrates,,deletion of the ecxll gene by
integration of the i'~i dIII fragment from pAEGIpyrG-3 at
the e=locus on one of the T. reesei chromosomes.
FIG. 13 is an outline of the construction of
pAAEGII-l.
DETAILED DESCRIPTION OF THE INVENTION
As noted above, the present invention generally
relates to methods for producing a substantially pure
EG III cellulase component whether in a polyethylene
glycol solution or as a recovered protein.
However, prior to discussing this invention in
further detail, the following terms will first be
def ined :
1. Definitions
As used herein the following terms have the
following meanings:
"EG III cellulase'" refers to the endoglucanase
component derived from Trichoderma suu. or any
CA 02133436 2003-08-08
V1'0 93/20208 PCT/US93/03251
- 9 -
microorganism producing a protein equivalent to EG III
produced by Trichoderma sDD. characterized by a pH
optimum of about 5.5 to 6.0, an isoelectric point (pI)
of from about 7.2 to 8.0, and a molecular weight of
about 23 to 28 Kdaltons. Preferably, EG III cellulase
is derived from either Trichoderma reesei or from
Trichoderma viride. EG III cellulase derived from
Trichoderma reesei has a pH optimum of about 5.5 to
6.0, an isoelectric point (pI) of about 7.4 and a
molecular weight of about 25 to 28 Kdaltons. EG III
cellulase derived from Trichoderma v' ' e has a pH
optimum of about 5.5, an isoelectric point (pI) of
about 7.7 and a molecular weight of about 23.5
Kdaltons. Additionally, it is contemplated that the
amino acid sequence of the EG III cellulase may be
altered. Alteration of the active sites on this enzyme
may lead to a variety of different changes such as
different pH optima, different temperature optima or
altered affinities for the substrate.
Because of its high pI, the EG I. -~omponent is
found in a region of an isoelectric focusing gel where
high pI xylanases and other high pI components
expressed by Trichoderma sDD. are generally found. In
fact, it has been hypothesized in the literature that
the band identified as EG III in FIG. 2 was a
degradation product of either EG I or II. However, gel
isoelectric focusing of EG I and EG II deleted
cellulase (prepared in the manner of WO 92/06210
and WO 92/17574) demonstrated that this band
was not attributable to a degradation product of either
EG I or II. (See FIG. 2).
It is noted that EG II has been previously
referred to by the nomenclature "EG III" by some
authors but current nomenclature uses the term "EG II'=.
In any event, the EG II protein is substantially
WO 93/20208 PCT/US93/0325
2133136
-io-
different from the EG III protein in its molecular
weight, pI, and pH optimum as evidenced by Table 2 of
Example 2 presented below. "Substantially pure EG III cellulase" refers to a
composition, solid or liquid, of cellulase proteins
containing at least 50 weight percent, more preferably
at least 70 weight percent and most preferably at least
90 weight percent of EG III cellulase component based
on the total weight of cellulase proteins.
"Substantially free of all other cellulase
proteins," refers to a composition in which at least 50
weight percent, more preferably 60 weight percent and
most preferably at least 90 weight percent of the
cellulase proteins, other than EG III, have been
removed from the original aqueous mixture of cellulase
enzymes.
"Enriched in xylanase" refers to an aqueous
solution or compopition, or polyethylene glycol phase
containing an increase in xylanase concentration by the
processes of this invention by at least a factor of 4,
more preferably by at least a factor of 10.
"Cellulase proteins" refer to cellulase proteins
which contain any and all exo-cellobiohydrolase (CBH)
proteins, endoglucanase (EG) proteins and B-glucosidase
(BG) proteins derived from wild-type fungal sources or
microorganisms genetically modified so as to
incorporate and express all or part of the cellulase
genes obtained from a wild-type fungal sources.
,Collectively, all of such proteins (i.e., CBH, EG and
BG proteins) are referred to as "cellulase proteins".
Contrarily, cellulase proteins do not include other
proteins expressed by Trichoderma sDu. including
xylanases, proteases, amylases, etc.
"Endoglucanase (EG) components" refer to the EG
components of Trichoderma spQ. including the EG I, EG
CA 02133436 2003-08-08
WO 93/20208 PCT/US93/03251
- 11 -
II and/or EG III components of Trichoderma reesei.
The endoglucanase components of Trichoderma sn,p. (eg.,
the EG I, EG II, EG III,of T. reesei), either alone or
in combination, impart improved feel, improved
appearance, softening, color enhancement, and/or a
stone washed appearance to cotton-containing fabrics
(as compared to the fabric prior to treatment) when
these components are incorporated into a textile
treatment medium and the fabric is treated with this
medium. In addition to the above, EG III possesses
substantial activity at alkaline pHs where many
detergent compositions are employed.
"Exo-cellobiohydrolase ("CBH") components" refer
to the CBH components of Trichoderma spp. including the
CBH I and CBH II components of Trichode~na reesei.
When used in the absence of the EG components of
Trichoderma spv., the CBH components of Trichoderma
SpD. alone do not impart significant color
retention/restoration and improved feel to the so-
treated cotton-containing fabrics. Additionally, when
used in combination with such EG components, the CBH 1
component of Trichoderma reesei can impart enhanced
strength loss and incremental cleaning benefits to
cotton-containing fabrics.
"8-Glucosidase (BG) components" refer to those
components of cellulase which exhibit BG activity; that
is to say that such components will act from the non-
reducing end of cellobiose and other soluble
cellooligosaccharides ("cellobiose") and give glucose
as the sole product. BG components do not adsorb onto
or react with cellulose polymers. Furthermore, such BG
components are competitively inhibited by glucose (K;
approximately 1mM). While in a strict sense, BG
components are not literally cellulases because they
cannot degrade cellulose, such BG components are
WO 93/20208 2133436
PCT/US93/0325"'
- 12 -
included within the definition of the cellulase system
because these enzymes facilitate the overall
degradation of cellulose by further degrading the
inhibitory cellulose degradation products (particularly
cellobiose) produced by the combined action of CBH
components and EG components. Without the presence of
BG components, moderate or little hydrolysis of
crystalline cellulose will occur. BG components are
often characterized on aryl substrates such as p-
nitrophenol B-D-glucoside (PNPG) and thus are often
called aryl-glucosidases. It should be noted that not
all aryl-glucosidases are BG components, in that some
do not hydrolyze cellobiose.
2. Methodoloav
A. Recovery of EG III with Polyethylene Glycol
The present invention is directed in part to the
discovery that EG III cellulase substantially free of
other cellulase proteins can be obtained from an
aqueous mixture of cellulase proteins containing EG III
by the addition of a specified polyethylene glycol.
Surprisingly, under'these conditions substantially all
of the cellulase proteins, other than EG III, remain in
the aqueous phase whereas the EG III is recovered in
the polyethylene glycol phase in substantially pure
quantities. It has also been found that under these
conditions, enriched quantities of xylanase are
recovered in the polyethylene glycol phase.
In one preferred method of carrying out the
present invention, an aqueous mixture containing
cellulase was filtered to remove cell debris and other
solids and produced a liquid filtrate containing a
CA 02133436 2003-08-08
WO 93/20208 PC'T/US93/03251
- 13 -
mixture of proteins including cellulase proteins. More
preferably a cell-free cellulase protein mixture, such
~
as CYTOLASE 123 (commercially available from Genencor
International, Inc., South San Francisco, California)
is used. In another method the aqueous mixture could
be obtained from any compatible source including
compatible aqueous mixtures already enriched for EG
III, more particularly any of the EG III solutions
described in
After the filtrate is obtained from the filtration
step, an inorganic salt may be added to the filtrate
before contacting the filtrate with the polyethylene
glycol (PEG). In some cases, the addition of inorganic
salts may enhance the partition of the EG III cellulase
component from the aqueous phase into the polyethylene
glycol phase.
The polyethylene glycol is then mixed with the
aqueous mixture for a period of time sufficient to
effect transfer of substantial quantities of EG III to
the polyethylene glycol phase. The specific period of
time will vary depending on the amount of polyethylene
glycol added, the amount of salt added, and the like.
Such factors are readily ascertained by the skilled
artisan. However, in a preferred embodiment, the
polyethylene glycol is mixed with the aqueous mixture
for at least about 2 hours, more preferably about 4
hours, and most preferably about 18 hours. The
polyethylene glycol aqueous mixture is allowed to
settle after mixing for a period of time sufficient to
effect phase separation and preferably for at least
about 4 hours, more preferably 8 hours, most preferably
* trade-anark
WO 93/20208 2133436 PCT/US93/0325:~~
14
about 18 hours. A two-phase liquid mixture is formed.
The EG III cellulase component is present in the
polyethylene glycol phase. The polyethylene glycol EG
III-rich phase is then separated from the aqueous
phase. The recovered EG III-rich solution contains a
mixture-of cellulase protein wherein from about 50 to
greater than 90 weight percent of these proteins are EG
III.
The EG III component can be purified from the
polyethylene glycol phase by a variety of methods. In
a preferred embodiment, the EG III cellulase component
is precipitated with cold ethanol and resuspended in a
desired aqueous solution. Suitable buffers are buffers
known in the art which do not denature the EG III
cellulase component such as 50 mM sodium acetate, pH 5,
or 10 mM citrate phosphate, pH 5.
One of the essential features of this aspect of
the invention is the use of polyethylene glycol (PEG).
The PEG has been found to be uniquely active and
selective for recovering EG III cellulase from aqueous
mixtures containing other cellulase proteins. In this
regard, an "effective amount of polyethylene glycol" is
that amount added to the aqueous mixture which is
necessary to selectively partition a sufficient amount
of the EG III component but not the other cellulase
proteins. The amount of polyethylene glycol added is
preferably from about 0.5o wt/v. to 10% wt/v., more
preferably 4% wt/v. The average molecular weight of
P;EG used in the.method of this invention is from about
5,000 to 10,000, preferably from about 7,000 to 9,000
and most preferably about 8,000.
Regarding the above procedure, use of a
polyethylene glycol having a molecular weight
substantially less than about 5,000 gave reduced
separation from the other cellulase enzymes; whereas,
,yV0 93/20208 PCT/US93/03251
- 15 -
use of polyethylene glycol having a molecular weight
substantially greater than about 10,000 resulted in
reduced capture of the EG III cellulase componentMfrom
the PEG phase. In a preferred embodiment, the molecular
weight of the polyethylene glycol is about 8,000.
The polyethylene glycol has been found to be
particularly useful in separating the EG III cellulase
component from an aqueous mixture of cellulase proteins
because the aqueous mixture contains a high percentage
of other cellulase proteins relative to the percentage
of EG III. The normal distribution of cellulase
proteins in the CYTOLASE 123 cellulase system is as
follows:
CBH I 45-55 weight percent
CBH II 13-15 weight percent
EG I 11-13 weight percent
EG II 8-10 weight percent
EG III 1-4 weight percent
BG 0.5-1 weight percent
Useful quantities of EG III component are obtained by
the methods of this invention. The loss of recovery of
the EG III component by the PEG extraction methods of
this invention as compared to other methods is
compensated for by the speed of recovery of the EG III
component. The procedure does not require extensive
fractionation steps for purification, although such
steps can be followed for further purification, if
desired.
The term "inorganic salt" means a compatible
inorganic salt having a sulfate or phosphate ion whic~i
when used in conjunction with the polyethylene glycol
facilitates purification of EG III without denaturing
the protein. Such inorganic salts include by way of
example, sodium sulfate, magnesium sulfate, ammonium
sulfate, sodium phosphate and potassium phosphate. An
2133436 WO 93/20208 PCT/US93/032';,7"'
- 16 -
"effective amount of inorganic salt" is that amount
which when added to an aqueous mixture containing
polyethylene glycol wili result in the preferential
separation of the EG III component into the
polyethylene glycol phase and the retention of the
cellulase proteins, other than EG III, in the aqueous
phase.
The concentration of the inorganic salts can be
varied to provide the desired result. It has been
found that the EG III cellulase component is
sequestered in the PEG phase best in the presence of a
concentrated salt solution of from about 4% to 20%
wt/vol, more preferably a concentrated salt solution of
10% to 14% wt/vol. It has been found that salt levels
substantially greater than about 20% wt/vol caused
precipitation problems; whereas, salt levels
substantially less than about 4% wt/vol gave poor
separation or. the solution remained in a single phase.
B. Recovery of EG III Cellulase by Fractionation
In another preferred method of carrying out the
process of the present invention, EG III is recovered
from a filtered aqueous mixture containing cellulase
proteins, such as CYTOLASE 123 cellulase, by
fractionation. Such fractionation can be achieved by
desalting the aqueous mixture at appropriate stages
using an appropriate desalting resin and separating EG
III by using a cation exchange resin and anion exchange
resin. Specifically, EG III has been recovered by
first desalting the aqueous mixture with a Sephadex G-
25 gel filtration resin column using 10 mM sodium
phosphate buffer at pH 6.8. The desalted solution, is
then loaded onto a QA Trisacryl M anion exchange resin
CA 02133436 2003-08-08
WO 93/20208 PCT/LJS93/03251
- 17 -
column. The fraction not bound oz_ -ais column contains
EG III. This fraction is desalted using a Sephadex G-
25 gel filtration resin column equilibrated with 10 mM
sodium citrate, pH 4.5. This solution is loaded onto a
*
SP Trisacryl M cation exchange resin column. The EG
III cellulase component is eluted with an aqueous
solution of 200 mM sodium chloride.
In another preferred method of carrying out the
process of the present invention, the EG III sample
obtained from the cation exchange column can.be further
fractionated. The EG III sample is desalted with a
Sephadex G-25*column which had been previously
equilibrated with 10 mM sodium citrate pH 4. The
solution was applied to a FPLC system using a Mono-S-HR
5/5 column (available from Pharmacia LKB Biotechnology,
Piscataway, NJ). The column is then eluted with 0-200
mM aqueous gradient of sodium chloride at a rate of 0.5
ml/minute. The EG III cellulase component was
recovered and was determined to be greater than 90%
pure by gel electrophoresis. EG III of this purity is
suitable for determining the N-terminal amino acid
sequence by known techniques.
Sepharose resins are a well-known class of resins.
As used herein, "sepharose" refers to any sepharose
resin having a sufficient exclusion size to retain the
salt but exclude the EG III. As used herein, an "anion
exchange resin" refers to any resin having cationic
functional groups providing sufficient charge density
to bind at least some of the cellulase proteins other
than EG III at a pH below the pH of EG III. Suitable
anionic resins contain aminoethyl (AE),
diethylaminoethyl (DEAE) and quaternary aminoethyl
(QAE) functional groups. As used herein, a "cation
exchange resin" refers to any resin containing anion
functional groups providing sufficient charge density
* trade-mark
CA 02133436 2003-08-08
WO 93/20208 PCT/US93/03251
- 18 -
to bind EG III at a pH below the pI of EG III.
Suitable compatible cationic resins contain
sulphopropyl (SP), phospho (P) and carboxymethyl (CM)
functional groups.
It may be desirable for the EG III cellulase
components described above to be further purified. For
example, the EG III cellulase component isolated in the
procedures described above can be further purified by
utilizing material obtained from the first PEG
extraction procedure in the second fractionation
procedure, or vice versa.
The EG III recovered herein can also be further
purified by the methods recited in U.S. Patent No. 5,320,960.
It will be recognized that the above descriptions
are preferred methods of carrying out the process of
the present invention and that numerous variations of
the above methods can be made in the process following
the teachings of this invention. The various process
conditions can be altered and reagents used can be
changed to provide various desired or optimum operating
conditions for recovery of the EG III cellulase
component from any suitable aqueous mixture of enzymes
containing the EG III component.
As will be recognized by those skilled in the art,
the acids, bases and salts referred to above in the
description of the process of this invention can be
changed or substituted with equivalent acids, bases or
salts which provide the desired pH or the desired salt
content without interfering with the operation of the
,..WO 93/20208 2133 ~.~; 36 PC.T/US93/03251
19 - '
invention and which do not denature the EG III
cellulase component.
Additionally, the fractionation method of this
invention can be preceded by the extraction method of
this invention or vice versa. The aqueous mixture can
be extracted with polyethylene glycol so as to provide
for an initial polyethylene glycol EG III-rich phase
(about 50-90% pure EG III) which can then be further
purified by the fractionation method of this invention
to provide for an aqueous solution containing
substantially pure EG III cellulase.
EG III cellulase can be purified from any source
including strains of Trichoderma SDD. which produces EG
III under suitable fermentation conditions. While;the
particular source of EG III is not critical, preferred
sources are Trichodenna peesei and Trichoderma viride.
A particularly preferred source of EG III from
Trichoderma reesei is Cytolase 123 cellulase which is
commercially available from Genencor International,
Inc., 180 Kimball Way, South San Francisco, CA 94080.
Procedures suitable for obtaining substantially pure EG.
III cellulase from a complete cellulase system derived
from Trichoderma SDD. ("whole cellulase") include those
recited in the examples set forth herein below. These
examples demonstrate that substantially pure EG III
cellulase is readily obtained by subjecting whole
cellulase either to PEG extraction and/or to repeated
fractionation steps utilizing different fractionation
materials (columns).
In order to enhance the efficiency of the
isolation of EG III, it may be desirable to employ a
microorganism (e.g., Tri,choderiea reesei) genetically
modified so as to overexpress EG III and/or to be
incapable of producing one or more of EG I, EG II, CBH
1 and/or CBH II components. This will necessarily lead
CA 02133436 2003-08-08
WO 93/20208 PCT/US93/03251
- 20 -
to more efficient isolation of EG III by, for example,
fractionation and/or PEG extraction as described above.
Production of some of these strains of Trichoderma
reesei are disclosed in WO 92/06210 and in the
Examples below.
Additionally, it is contemplated that
substantially pure EG III cellulase can be prepared by
genetically modifying microorganisms so as to produce
substantially pure EG III cellulase. For example,
substantially pure EG III prepared by fractionation
methods set forth in the Examples below was employed to
determine the amino acid sequence of parts of the
protein using known sequencing methods (Example 4).
This information can be used to prepare synthetic DNA
probes in order to clone the gene encoding the EG III
cellulase component. Once the EG III gene is cloned,
it could be manipulated by recognized techniques and
ultimately inserted into various Trichoderma sDD.
strains or into other microorganisms. See, for
example, WO 92/17574 and WO 92/06210, both of which
disclose methods for genetically engineering
Trichoderma reesei so that the modified microorganism
is incapable of expressing one or more of the cellulase
genes and, in fact, may overproduce another cellulase
gene.
Using the methods described in these applications,
Trichoderma reesei can be genetically manipulated so as
to produce EG III with or without other cellulase
CA 02133436 2003-08-08
WO 93/20208 PCT/US93/03251
- 21 -
proteins. Moreover, the methods described in these
applications create Trichoderma reesei strains which do
not produce any heterologous proteins.
Additionally, it would be possible to express the
EG III-encoding gene in other microorganisms,
including, but not limited to, yeast species such as
Saccharomvices cerevisiae, ch'a pastoris, Hansenula
polymorpha, Eluyveromyces lactis, Yarrowia lioolvtica,
Schanniomyces occidentalis, etc. See, for example, PCT
application Publication No. WO 85/04672. Zn order to
obtain expressiondn these alternative, non-Trichoderma
hosts, it may be necessary to functionally combine the
EG III-coding DNA sequence with promoter and terminator
sequences obtained from a gene from that particular
host. It may also be necessary to substitute the DNA
sequence encoding a secretion signal sequence from the
alternative host for the DNA sequence encoding the EG
III secretion signal sequence. Production and
secretion of EG III in other organisms could enable EG
III to be obtained in substantially pure form.
The substantially pure EG III cellulase described
above can be further processed into a liquid diluent,
granules, emulsions, gels, pastes, or the like. Such
forms are well known to the skilled artisan. When a
solid detergent composition is desired, the cellulase
composition is preferably formulated as granules.
Preferably, the granules can be formulated so as to
contain a cellulase protecting.agent. See, for
instance, WO 91/17235.
Likewise, the granules
can be formulated so as to contain materials to reduce
CA 02133436 2003-08-08
WO 93/20208 PCr/US93/03251
- 22 -
the rate of dissolution of the granule into the wash
medium. Such materials and granules are disclosed in
U.S. Patent No. 5,254,283.
The granules or other
detergent formulations containing EG III can then be
used for cleaning fabrics, imparting softening
properties to the fabric and the like.
The following examples are offered to illustrate
the present invention and should not be construed in
any way as limiting the scope of this invention.
EZAMPLES
Example 1
Larce Scale Extraction o1 EG III Cellulase Enzyme
A. one hundred liters of cell free cellulase
filtrate were heated to about 30 C. The heated
material was made about 4% wt/vol CarbowaxT'd PEG 8000
(polyethylene glycol, average MW of about 8000) (Union
Carbide, Danbury, CT) and about 10% wt/volianhydrous
sodium sulfate. The mixture formed a two phase liquid
mixture The phases were separated using an SA-1 disk
stack centrifuge. The phases were analyzed using
silver staining isoelectric focusing gels.
Fractionation and enrichment were obtained for EG III
and xylanase. The recovered composition contained
about 20 to 50 weight percent of EG III. The amount of
xylanase recovered in the polyethylene glycol phase
represents enrichment of the xylanase by a factor of at
least 4.
.WO 93/20208 PCT/US93/03251
23 -
B. One hundred litres of cell-free cellulase
filtrate were added to a 130 liter container with a
cone bottom and an outlet at bottom center. The M
starting material can be whole cellulase or cellulase
from strains which have been deleted for cellulases
other than EG III and/or over expressed for EG III.
Ultrafiltration is not a necessary requirement;
however, the protein concentration should be kept to
about 10 to 50 g/L.
Next 4 kg of polyethylene glycol average molecular
weight 8000 and 14kg of ammonium sulfate were added to
the cellulase filtrate. The mixture was mixed in an
overhead mixer for 18 hours. After mixing, the phases
were allowed to.separate for 18 hours. The bottom
15. layer was removed through the bottom outlet in such a
way as to maintain the phase separation. The PEG phase
was collected and centrifuged at 5,000 xg for 30
minutes to remove any insoluble material. EG III
activity is stable in the polyethylene glycol solution.
Removal of the protein from the polyethylene
glycol exploits the fact that the polyethylene glycol
is soluble in ethanol and the protein is not. This
step also removes some of the salt and concentrates the
protein. 200 ml aliquots of the PEG phase and 800 ml
of cold (-200 C) ethanol were mixed well in one liter
centrifuge bottles and allowed to sit for approximately
18 hours at -20 C. The mixture was centrifuged at 5000
xg for 30 minutes, the solution was decanted and the
precipitate rinsed with deionized water.
The choice of buffer for dicsolution of the
precipitated protein depends on the chromatographic
steps which follow or, if this is the final step, in
producing an enriched EG III solution. Generally, the
buffer solutions are either 50 mM acetate, pH 5, or
WO 93/20208 2133136 PCT/US93/0325" .:-- 24 - 10 mM citrate phosphate, pH 4 in
preparation for cation
exchange chromatography.
Recovery for the PEG extraction can be determiried
based on RBB-CMC activity, and total volumes are as
shown below. The method of determining RBB-CMC
activity is described in Example 3.
Table 1
SAMPLE DIL. OD 590 OD/ml VOLUME ml TOTAL OD % RECOVERY
BROTH 40 .299 12.0 4000 47840 100
PEG 100 .193 19.3 510 9843 21
RAFFINATE 40 .234 9.36 3490 32666 68
Recovery of activity ranges from 15 to 30 percent into
the PEG phase. This step represents the highest loss
as a percentage of total endoglucanase activity if the
starting material is EG I/II deleted cellulase. The
loss due to each subsequent chromatographic step tends
to be small by comparison, approximately 20% or less
for each step.
Chromatoaraphy
The enriched EG III solution from Example I', part
(b) was diafiltered using an omega series tangential
flow 8,000 ultra filtration membrane (Filtron
Technology Corp., Northborough, MA) against 10 mM,-gffi-5
citrate/phosphate buffer. The solution was loaded onto
an equilibrated (pH 5, 10 mM citrate/phosphate) SP
Trisacryl column and the flow-through col3ected and the
pH-adjusted-to 4 w3th-0:5M ci.tric acid. T-#e--f-3~aw-
Jt3rraugh_ was--next 4-oaded-onto an equil.ibr-ated. (pH 4, 10
.mM.-.citrate/phosphate) SP Trisacryl column. The EG III
component was eluted with 250 mM sodium chloride..
CA 02133436 2003-08-08
WO 93/20208 PC'T/US93/03251
- 25 -
Example 2
Purification of EG III Via Fractionation
The purification of EG III is conducted by
fractionation from a complete fungal cellulase
composition (CYTOLASE 123 cellulase, commercially
available from Genencor International, South San
Francisco, CA) which is produced tt wild type
Trichoderma reesei. Specificall= the fractionation is
done using columns containing ti_ following resins:
Sephadex G-25 gel filtration resin from Sigma Chemical
Company (St. Louis, Mo), QA Trisacryl M*anion exchange
resin and SP Trisacryl M cation exchange resin from IBF
Biotechnics (Savage, Md). CYTOLASE 123 cellulase,
0.5g, is desalted using a column of 3 liters of
Sephadex G-25 gel filtration resin with 10 mM sodium
phosphate buffer at pH 6.8. The desalted solution, is
then loaded onto a column of 20 ml of QA Trisacryl M
anion exchange resin equilibrated with 10 mM sodium
phosphate buffer pH=6.8. The fraction bound on this
column contained CBH I and EG I. The fraction not bound
on this column contains CBH II, EG II and EG III.
These fractions are desalted using a column of Sephadex
G-25 gel filtration resin equilibrated with 20 mM
sodium citrate, pH 4.5. This solution, 200 ml, is then
loaded onto a column of 20 ml of SP Trisacryl M cation
exchange resin. The EG III was eluted with 100 mL of
an aqueous solution of 200 mM sodium chloride.
One particular method for further purifying EG III
is by further fractionation of an EG III sample
obtained in this Example 2. The fractionation was done
on a FPLC system using a Mono-S-HR 5/5 column
(available from Pharmacia LKB Biotechnology,
Piscataway, NJ). The FPLC system consists of a liquid
* trade-mark
WO 93/20208 PCT/US93/0325'
- 26 -
chromatography controller, 2 pumps, a dual path
monitor, a fraction collector and a chart recorder (all
of which are available from Pharmacia LKB
Biotechnology, Piscataway, NJ). The fractionation was
conducted by desalting 5 ml of the EG III sample
prepared in this Example 2 with a 20 ml Sephadex G-25
column which had been previously equilibrated with 10
mM sodium citrate pH 4. The solution was loaded onto
mono-S-HR 5/5 column previously.equilibrated with 10 mM
sodium citrate pH=4.0 and then eluted with 0-200 mM
aqueous gradient of NaCl.at a.rate of 0.5 mi/minute
with samples collected in 1 ml fractions. EG III was
recovered in(fractions'l0 and 11 and was determined to
be greater than 90% pure by,gel electrophoresis. EG
III of this purity is suitable for determining the N-
terminal amino acid sequence by known techniques.
Substantially pure EG III has.the following
characteristics which are compared to the other
endoglucanases isolated from Trichoderma reesei.
TABLE 2
MW DI vH ontimum1
EG I -47-49 kD 4.7 -5
EG II -35 kD 5.5 -5
EG III -25-28 kD 7.4 -5.5-6.0
1. pH optimum determined by RBB-CMC activity as
per Example 3 below.
As can be seen from the above table, EG III has
both a higher pH optimum and a higher pI as compared to
the other endoglucanase components of Trichoderma
WO 93/20208 ~} 3 J " PCT/US93/03251
- 27 -
reesei. In Example 3 below, it is seen that EG III
also retains significant RBB-CMC activity under
alkaline pHs.
Likewise, EG III cellulase from other sources
including other strains of can be purified by the above
methods. For example, EG III cellulase'derived from
Trichoderma viride has been described by Voragen et
al., Methods in Enzymology, 160:243-249. This
reference eescribes the EG III cellulase as having a
molecular weight of about 23.5 Kdaltons, a pH optimum
of 5.5, and a pI of 7.7.
In order to enhance the efficiency of the
isolation of EG III, it may be desirable to employ
Trichoderma reesei genetically modified so as to
overexpress EG III and/or to be incapable of producing
one or more of EG I, EG IT, CBH I and/or CBH II
components.
Likewise, it may be desirable for the EG III
compositions described above to be further purified.
For example, EG III protein isolated in Example 1 can
be further purified by the above procedures or vice
versa.
Example 3
" Activity of Cellulase Comnositions
Over a pH Ranae
The following procedure was employed to determine
the pH profiles of two different cellulase
compositions. The first cellulase composition was a
CBH I and II deleted cellulase composition prepared
from Trichoderma reesei genetically modified in a
manner similar to that described below so as to be
unable to produce CBH I and CBH II components. Insofar
CA 02133436 2003-08-08
WO 93/20208 PCT/US93/03251
- 28 -
as this cellulase composition does not contain CBH I
and CBH II which generally comprise from about 58 to 70
p--~-zt of a cellulase composition derived from
7- Dderma reesei, this cellulase composition is
nec, sarily enriched in EG components. Since EG III is
the most minor of the endoglucanase components of
Trichoderma reesei, this composition predominates in EG
I and EG II components.
The second cellulase composition was an
approximately 20-40% pure fraction of EG III isolated
from a cellulase composition derived from Trichoderma
reesei via purification methods similar to Example 2.
The activity of these cellulase compositions was
determined at 40 C and the determinations were made
using the following procedures.
Add 5 to 20 l of an appropriate enzyme solution
at a concentration sufficient to provide the requisite
amount of enzyme in the final solution. Add 250 l of
2 weight percent RBB-CMC (Remazol~Brilliant Blue R-
Carboxymethyl-cellulose -- commercially available from
MegaZyme, 6 Altona Place, North Rocks, N.S.W. 2151,
Australia) in 0.05M citrate/phosphate buffer at pH 4,
5, 5.5, 6, 6.5, 7, 7.5 and S.
Vortex and incubate at 40 C for 30 minutes. Chill
in an ice bath for 5 to 10 minutes. Add 1000 l of
methyl cellosolve containing 0.3M sodium acetate and
0.02M zinc acetate. Vortex and let sit for 5-10
minutes. Centrifuge and pour supernatant into cuvets.
Relative enzyme activity was determined by
measuring the optical density (OD) of the solution in
each cuvet at 590 nm. Higher levels of optical density
correspond to higher levels of enzyme activity.
The results of this analysis are set forth in FIG.
1 which illustrates the relative activity of the CBH I
and II deleted cellulase composition compared to the EG
* trade-mark
CA 02133436 2003-08-08
WO 93/20208 PCT/US93/03251
- 29 -
III cellulase composition. From this figure, it is
seen that the cellulase composition deleted in CBH I
and CBH II possesses optimum cellulolytic activity
against RBB-CMC at near pH 5.5 and has some activity at
alkaline pHs, i.e., at pHs from above 7 to 8. on the
other hand, the cellulase composition enriched in EG
III possesses optimum cellulolytic activity at about pH
5.5 - 6 and possesses significant activity at alkaline
pHs.
Examnle 4
Isoelectric Focusina Gels
The purpose of this example is to illustrate
isoelectric focusing gels of different EG III cellulase
compositions. Specifically, cellulase produced by a
wild type Trichoderma reesei; cellulase derived from a
strain of Trichoderma reesei transformed by the method
of Examples 16 and 17 so as to be incapable of
expressing EG I and EG II cellulase proteins; and
substantially pure EG III cellulase by the method
similar to that of Example 1 were analyzed on
isoelectric focusing gels.
Samples of these cellulases were analyzed by
isoelectric focusing using a Pharmacia IEF*system (FBE-
3000, Pharmacia Inc., Piscataway, NJ) and pH 3-10
precast gels (Servalyt Precote, available from Serva,
Carl-Berg, Germany) according to the manufacturer's
instructions. The gels were stained with EphortecTM
stain (Serva Blue W, available from Serva Fine
Biochemicals, Westbury, NY 11590) to visualize the
protein bands. The resulting gel is set forth in FIG.
2 wherein Lane 1 of FIG. 2 illustrates the isoelectric
* trade-mark
CA 02133436 2003-08-08
WO 93/20208 PCT/US93/03251
- 30 -
focusing gel of cellulase derived from a wild strain
Trichoderma reesei; Lane 2 illustrates the isoelectric
focusing gel of cellulase derived from a strain of
Trichoderma reesei so as to be incapable of expressing
EG I and II; and Lane 3 illustrates the isoelectric
focusing gel of substantially pure EG III cellulase.
In this figure, the margin adjacent to Lane 1 is marked
to identify the bands corresponding to cellulase
proteins so as to permit identification of the
proteins.
From the above figure, it is seen that because of
EG III's high pI, this protein is found in a region
usually associated with other high pI components such
as high pI xylanases, high pI 8-glucosidases, etc.
Moreover, this Figure demonstrates that EG III is not a
degradation product of either EG I or EG II proteins
because, in Lane 2 of this Figure, these proteins are
not present while the EG III protein is.
Example 5
Peptide Seauencing of EGIII
The EG III component was precipitated by the
addition of 0.9 ml of acetone to 0.1 ml of protein
solution (at a concentration of 1 mg/ml) and incubation
at -20 C.for 10 minutes. The protein was collected by
centrifugation and the pellet dried and resuspended in
0.01 ml of 8 M urea in 88% formic acid and 0.01 ml of
cyanogen bromide (200 mg\ml) in 88% formic acid. The
mixture was incubated at room temperature for four
hours.
Individual peptides were purified on a HPLC (high
pressure liquid chromatography) column. A Synchropak
RP-4* column was equilibrated in deionized milliQ*water
* trade-mark
CA 02133436 2003-09-11
WO 93/20208 PCT/US93/03251
- 31 -
with 0.05% TEA (triethylamine) and 0.05% TFA
(trifluoroacetic acid). The sample was loaded onto the
HPLC column and elution was carried out with 100%
acetonitrile and 0.05% TEA and 0.05% TFA, with a
qradient of 1% per minute. The amino-terminal regions
of isolated peptides were sequenced by the method of
Edman using a fully automated apparatus. The amino
acid sequence obtained from two fragments of the EG III
component are shown in FIG. 3
Example 6
Selection for nvr4' derivatives of Trichoderma reesei
The pyrh gene encodes orotidine-51-monophosphate
decarboxylase, an enzyme required for the biosynthesis
of uridine. The toxic inhibitor 5-fluoroorotic acid
(FOA) is incorporated into uridine by wild-type cells
and thus poisons the cells. However, cells defective
in the Dvr4 gene are resistant to this inhibitor but
require uridine for growth. It is, therefore, possible
to select for pvr4 derivative strains using FOA. In
practice, spores of T. reesei strain RL-P37 (Sheir-
Neiss, G. and Montenecourt, B.S., Appl. Microbiol.
Biotechnol. 20, p. 46-53 (1984)) were spread on the
surface of a solidified medium containing 2 mg/ml
uridine and 1.2 mg/ml FOA. Spontaneous FOA-resistant
colonies appeared within three to four days and it was
possible to subsequently identify those FOA-resistant
derivatives which required uridine for growth. In
order to identify those derivatives which specifically
had a defective p,yyr4 gene, protoplasts were generated
and transformed with a plasmid containing a wild-type
pvr4 gene (see Examples 8 and 9). Following
CA 02133436 2003-08-08
WO 93/20208 PCr/US93/03251
- 32 -
transformation, protoplasts were plated on medium
lacking uridine. Subsequent growth of transformed
colonies demonstrated complementation of a defective
pyr4 gene by the plasmid-borne pyr4 gene. In this way,
strain GC69 was identified as a pyr4- derivative of
strain RL-P37.
Example 7
Preparation of CBHI Deletion Vector
A cbhl gene encoding the CBHI protein was cloned
from the genomic DNA of T. reesei strain RL-P37 by
hybridization with an oligonucleotide probe designed on
the basis of the published sequence for this gene using
known probe synthesis methods (Shoemaker et al.,
1983b). The cbhl gene resides on a 6.5 kb = I
fragment and was inserted into PstI cut pUC4K*(pur-
chased from Pharmacia Inc., Piscataway, NJ) replacing
the Kan' gene of this vector using techniques known in
the art, which techniques are set forth in Maniatis et
al. (1989) and incorporated herein by reference. The
resulting.plasmid, pUC4K::cbh1 was then cut with
HindIII and the larger fragment of about 6 kb was
isolated and religated to give pUC4K::cbh1AH/H (see
FIG. 4). This procedure removes the entire cbhl coding
sequence and approximately 1.2 kb upstream and 1.5 kb
downstream of flanking sequences. Approximately, 1 kb
of flanking DNA from either end of the original ~ts I
fragment remains.
* trade-mark
CA 02133436 2003-08-08
WO 93/20208 PCT/US93/03251
- 33 -
The T. reesei pvr4 gene was cloned as a 6.5 kb
indIII fragment of genomic DNA in pUC18 to form pTpyr2
(Smith et al., 1991) following the methods of Maniatis
et al., su a. The plasmid pUC4K::cbhIOH/H was cut
with = dIII and the ends were dephosphorylated with
calf intestinal alkaline phosphatase. This end
dephosphorylated DNA was ligated with the 6.5 kb
I,~~ndIII fragment containing the T. reesei gvr4 gene to
give pACBHIpy~4. FIG. 4 illustrates the construction
of this plasmid.
Examvle 8
Isolation of Protoplasts
Mycelium was obtained by inoculating 100 ml of YEG
(0.5% yeast extract, 2% glucose) in a 500 ml flask with
about 5 x 107 T. reesei GC69 spores (the pvr4-
derivative strain). The flask was then incubated at
37 C with shaking for about 16 hours. The mycelium was
harvested by centrifugation at 2,750 x g. The
harvested mycelium was further washed in a 1.2 M
sorbitol solution and resuspended in 40 ml of a
solution containing 5 mg/ml NovozymA 234 solution (which
is the trade name for a multicomponent enzyme system
containing 1,3-alpha-glucanase, 1,3-beta-glucanase,
laminarinase, xylanase, chitinase and protease from
Novo Biolabs, Danbury, CT); 5 mg/ml MgSO4.7H2O; 0.5
mg/ml bovine serum albumin; 1.2 M sorbitol. The
protoplasts were removed from the cellular debris by
filtration through Miracloth*(Calbiochem Corp, La
Jolla, CA) and collected by centrifugation at 2,000 x
g. The protoplasts were washed three times in 1.2 M
sorbitol and once in 1.2 M sorbitol, 50 mM CaC12,
* trade-mark
WO 93/20208 2133436 PCT/US93/0325 "..
- 34 -
centrifuged and resuspended at a density of
approximately 2 x 108 protoplasts per ml of 1.2 M
sorbitol, 50 mM CaC12. M
Examule 9
Transformation of FunQal Protoplasts with p CBHIpvr4
200 Ecl of the protoplast suspension prepared in
Example 8 was added to 20 l of EcoRI digested
pACBHIpyr4 (prepared in Example 7) in TE buffer (10 mM
Tris, pH 7.4; 1 mM EDTA) and 50 l of a polyethylerae
glycol (PEG) solution containing 25% PEG 4000, 0.6 M
KC1 and 50 mM CaC12. This mixture was incubated on ice
for 20 minutes. After this incubation period 2.0 ml of
the above-identified PEG solution was added thereto,
the solution was further mixed and incubated at room
temperature for 5 minutes. After this second
incubation, 4.0 ml of a solution containing 1.2 M
sorbitol and 50 mM CaCl2 was added thereto and this
solution was further mixed. The protoplast solution
was then immediately added to molten aliquots of
Vogel's Medium N (3 grams sodium citrate, 5 grams
KH2PO4, 2 grams NHeNO31 0.2 grams MgSO4.7H20, 0.1 gram
CaC12.2H20, 5 g a-biotin, 5 mg citric acid, 5 mg
ZnSO4. 7H20, 1 mg Fe(NH4) 2. 6H20, 0.25 mg CuSO4. 5Hz0, 50 Ag
MnSO4.4H20 per liter) containing an additional 1%
glucose, 1.2 M sorbitol and 1% agarose. The
protoplast/medium mixture was then poured onto a solid
medium containing the same Vogells.medium as stated
above. No uridine was present in the medium and
therefore only transformed colonies were able to grow
as a result of complementation of the p~r4 mutation of
strain GC69 by the wild type pvr4 gene insert in
CA 02133436 2003-08-08
WO 93/20208 PCT/US93/03251
- 35 -
pACBHIpyr4. These colonies were subsequently
transferred and purified on a solid Vogel's medium N
containing as an additive, 1$ glucose and stable
transformants were chosen for further analysis.
At this stage stable transformants were
distinguished from unstable transformants by their
faster growth rate and formation of circular colonies
with a smooth, rather than ragged outline on solid
culture medium lacking uridine. In some cases a
further test of stability was made by growing the
transformants on solid non-selective medium (i.e.
containing uridine), harvesting spores from this medium
and determining the percentage of these spores which
will subsequently germinate and grow on selective
medium lacking uridine.
Example 10
Analysis of the Transformants
DNA was isolated from the transformants obtained
in Example 9 after they were grown in liquid Vogel's
medium N containing 1% glucose. These transformant DNA
samples were further cut with astI restriction enzyme
and subjected to agarose gel electrophoresis. The gel
was then blotted onto a Nytran membrane filter and
hybridized with a nP-labelled pOCBHIpvr4 probe. The
probe was selected to identify the native cbhl gene as
a 6.5 kb ~ts I fragment, the native pyr4 gene and any
DNA sequences derived from the transforming DNA
fragment.
The radioactive bands from the hybridization were
visualized by autoradiography. The autoradiograph is
seen in FIG. 6. Five samples were run as described
above, hence samples A, B, C, D, and E. Lane E is the
* trade-mark
~ 1331136
WO 93/20208 ~~
PCTlUS93/032.;~: ; -:
- 36 -
untransformed strain GC69 and was used as a control in
the present analysis. Lanes A-D represent
transformants obtained by the methods described above.
The numbers on the side of the autoradiograph represent
the sizes of molecular weight markers. As can be seen
from this autoradiograph, lane D does not contain the
6.5 kb CBHI band, indicating that this gene has been
totally deleted in the transformant by integration of
the DNA fragment at the cbhl gene.= The cbhl deleted
strain is calledP37POCBHI. Figure 5 outlines the
deletion of the T. reeseicbhl gene by integration
through a double cross-over event of the larger EcoRI
fragment from pACHHIpvr4 at the cbhl locus on one of
the T. reeseichromosomes. The other transformants
analyzed appear identical to the untransformed control
strain.
Examnle ii
Analysis of the Transformants withpIntCBHI
The same procedure was used in this example as in
Example 10, except that the probe used was changed to a
32P-labelled pIntCBHI probe. This probe is a; pUC-type
plasmid containing a 2 kb.Bc,II fragment from the cbhl
locus within the region that was deleted in
pUC4K::cbh1AH/H., Two samples were run in this example
including a control, sample A, which is the untrans-
formed strain~ GC69, and the transformant P37PaCBHI,
sample B. As can be seen in FIG. 7, sample A contained
the cbhl gene, asindicated by the band at 6.5 kb;
however the transformant,;sample B, does not contain
this 6.5 kb band andtherefore does not contain the
cbhl gene and does not containany sequences derived
from the pUC plasmid.
2 1 '334 3'~
WO 93/20208 PCT/US93/03251
- 37 -
Example 12
Protein Secretion by Strain P37PACBHI
Spores from the produced P37P CBHI strain were
inoculated into 50 ml of a Trichoderzna basal medium
containing 1% glucose, 0.14% (NH4) 2SO41 0.2% KH2PO41 0.03%
MgS041 0.03% urea, 0.75% bactotryptone, 0.05% Tween 80,
0.000016% CuSO4.5H201 0.001% FeSO4.7H20, 0.000128%
ZnSO4.7H20, 0.0000054% Na2M O4.2H20, 0.0000007g
MnC1.4H20). The medium was incubated with shaking in a
250 ml flask at 37 C for about 48 hours. The resulting
mycelium was collected by filtering through Miracloth
(Calbiochem Corp.) and washed two or three times with
17 mM potassium phosphate. The mycelium was finally
suspended in 17 mM potassium phosphate with 1 mM
sophorose and further incubated for 24 hours at 30 C
with shaking. The supernatant was then collected from
these cultures and the mycelium was discarded. Samples
of the culture supernatant were analyzed by isoelectric
focusing using a Pharmacia Phastgel system and pH 3-9
precast gels according to the manufacturer's
instructions. The gel was stained with silver stain to
visualize the protein bands. The band corresponding to
the cbhl protein was absent from the sample derived
from the strain P37P CBHI, as shown in FIG. S. This
isoelectric focusing gel shows various proteins in
different supernatant cultures of T. reesei. Lane A is
partially purified CBHI; Lane B is the supernatant from
an untransformed T. reesei culture; Lane C is the
supernatant from strain P37PACBHI produced according to
the methods of the present invention. The position of
various cellulase components are labelled CBHI, CBHII,
EGI, EGII, and EGIII. Since CBHI constitutes 50% of
the total extracellular protein, it is the major
CA 02133436 2003-08-08
WO 93/20208 PCT/US93/03251
- 38 -
secreted protein and hence is the darkest band on the
gel. This isoelectric focusing gel clearly shows
depletion of the CBHI protein in the P37PACBHI strain.
Example 13
Preparation of pPdCBHII
The cb 2 gene of T. regsei, encoding the CBHII
protein, has been cloned as a 4.1 kb EcoRI fragment of
genomic DNA which is shown diagrammatically in FIG. 9A
(Chen et al., 1987, B}Qtechnology, 5:274-278). This
4.1 kb fragment was inserted between the EcoRI sites of
pUC4XL:The latter plasmid is a pUC derivative
(constructed by R.M. Berka, Genencor International
Inc.) which contains a multiple cloning site with a
symmetrical pattern of restriction endonuclease sites
arranged in the order shown here: coRI, ~a HI, SacI,
maI, = dIII, XhoI, DaIII, C1aI, = II, XhoI, HindIll,
smaI, Sacl, amHi, coRI. Using methods known in the
art, a plasmid, pPGCBHII (FIG. 9B), has been
constructed in which a 1.7 kb central region of this
gene between a= dIII site (at 74 bp 3' of the CBHII
translation initiation site) and a ClaI site (at 265 bp
3' of the last codon of CBHII) has been removed and
replaced by a 1.6 kb = dIII- = I DNA fragment
containing the T. reesei pvr4 gene.
The T. reesei gvr4 gene was excised from pTpyr2
(see Example 7) on a 1.6 kb N#}gI-= I fragment and
inserted between the SDhI and C aI sites of pUC219 to
create p219M (Smith et al., 1991, Curr. Genet, 19 p.
27-33). The pyr4 gene was then removed as a Fii dIII-
C aI fragment having seven bp of DNA at one end and six
bp of DNA at the other end derived from the pUC219
multiple cloning site and inserted into the HindIII and
* trade-mark
WO 93/20208 2
~ ~ ~ ~ ~ ~ PCTlUS93/03251
39 -
C1aI sites of the cbh2 gene to form the plasmid
pPACBHII (see FIG. 9B).
Digestion of this plasmid with EcoRI will liberate
a fragment having 0.7 kb of flanking DNA from the cbh2
locus at one end, 1.7 kb of flanking DNA from the cbh2
locus at the other end and the T. reesei pyr4 gene in
the middle.
Example 14
Generation of a pyr4' Derivative of P37P0CBHI
Spores of the transformant (P37PdCBHI) which was
deleted for the cbhl gene were spread onto medium
containing FOA. A Pyr4- derivative of this transformant
=was subsequently obtained using the -=ethods of Example
6. This pvr4* strain was designater . 137PQCBH' ?yr'26.
EXamgle 15
Deletion of the cbh2 Gene in a Strain
Previously Deleted for cbhl
Protoplasts of strain P37PACBHIPyr'26 were
generated and transformed with coRS digested pP CBHII
,
ac,-:)rding to the methods outlined in Examples 8 and 9.
Purified stable transformants were cultured in
shaker flasks as in Example 12 and the protein in the
culture supernatants was examined by isoelectric
focusing. One transformant (designated P37PAACBH67)
was identified which did not produce any CBHII protein.
Lane D of FIG. 8 shows the supernatant from a
WO 93/20208 2133436 PCr/US93/032'z.F'"'
- 40 -
transformant deleted for both the cbhl and cbh2 genes
produced according to the methods of the present
invention.
DNA was extracted from strain P37PAL1CBH67,
digested with EcoRI and As 718, and subjected to
agarose gel electrophoresis. The DNA from this gel was
blotted to a membrane filter and hybridized with nP-
labelled pPACBHII (FIG. 10). Lane A of FIG. 10 shows
the hybridization pattern observed for DNA from an
untransformed T. reesei strain. The 4.1 kb EcoRI
fragment containing the wild-type cbh2 gene was
observed. Lane B shows the hybridization pattern
observed for strain P37PAACBH67. The single 4.1 kb
band has been eliminated and replaced by two bands of
approximately 0.9 and 3.1 kb. This is the expected
'pattern if a single copy of the EcoRI fragment from
pPACBHII had integrated precisely at the cbh2 locus.
The same DNA.samples were also digested with ~cc RI
and Southern blot analysis was performed as above. In
this Example, the probe was 32P-labelled pIntCBHII.
This plasmid contains a portion of the cbh2 gene coding
sequence from within that segment of the cbh2 gene
which was deleted in plasmid pPQCBHII. No
hybridization was seen with DNA from strain P37PAGCBH67
showing that the cbh2 gene was deleted and that no
sequences derived from the pUC plasmid were present in
this strain.
Example 16
Construction of nAEGInyr-3 and Iransformation
of a ovr4 deficient strain of 1. reesei
The T. reesei eqll gene, which encodes EGI has
been cloned as a 4.2 kb HindiII fragment of genomic DNA
from strain RL-P37 by hybridization with
CA 02133436 2003-08-08
WO 93/20208 PCT/US93/03251
- 41 -
oligonucleotides synthesized according to the published
sequence (Pentilla et al., 1986, Gene, 45: 253-263; van
Arsdell et al., 1987, Bio/Technology, 5: 60-64).
This DNA fragment was inserted at the ~'rdIII site
of pUC100.* An internal 1 kb coRV fragment which
extended from a position close to the middle of the EGI
coding sequence to a position beyond the 3' end of the
coding sequence was removed by enzyme digestion and was
replaced by ligation with a 2.2 kb Ham1iI -HindIII
fragment containing the cloned A. niaer py,rQ gene
(Wilson et al., 1988, Nuci. Acids Res. 1~ p. 2339) to
give pOEGIpyrG-3 (FIG. 11). Transformation of a gvr4
deficient strain of T. reesei (strain GC69) by the
method set forth in Examples 8 and 9, with pOEGIpyr-3,
after it had been digested with i'~dIII to release the
fragment containing the py~G gene with flanking regions
from the eall'locus at either end, led to transformants
in which the genomic egll gene was disrupted by a
mechanism outlined in FIG. 12. DNA was extracted from
transformants, digested with ~õ'r~dIiI, subjected to
agarose gel electrophoresis and blotted onto a membrane
filter. The filter was hybridized with radiolabelled
p,&EGIpyr-3. In the untransformed strain of T. reesei
the eall gene was present on a 4.2 kb =dIII fragment
of DNA. However, following deletion of the eall gene
by integration of the desired fragment from p,&EGIpyr-3
this 4.2 kb HindIII fragment disappeared and was
replaced,by a#i n III fragment approximately 1.2 kb
larger in size. This pattern was observed for one
transformant, which was designated AEGI-3.
* trade-mark
WO 93/20208 '213 3 43 6 PCT/US93/032~~' '
- 42 -
ExamAle 17
Construction of PAAEGII-1 and
Deletion of the EG II Gene
e e 3 gene, encoding EG II (also referred to in
the litt--rature as EG III), was cloned from T. reesei
strain RL-P37 as a 4 kb PstI genomic DNA fragment by
hybridization with oligonucleotides synthesized
according to the published sequence (Saloheimo et al.,
1988, Gene 63:11-21). This DNA fragment was inserted
into the PstI site of pUC18. This plasmid, pEGII, was
subsequently digested with EcoRV to remove the entire
EG II coding region on an approximately 2 kb segment
extending from a position approximately 180 bp 5' of
the EGII coding region to a position a few hundred base
pairs beyond the end of the coding region. This
segment was replaced with an SspI fragment,of
Aspergillus nidulans genomic DNA containing the amdS
gene (Corrick et al., 1987, Gene 53:63-71) to create
plasmid PADEGII-1 (See FIG. 13).
Wild-type strains of T. reesei are unable to grow
on acetamide as a sole nitrogen source. Transformation
with the a S gene confers this ability and this is the
basis for the selection system for transformants
containing this gene.
Protoplasts of strain AEGI-3 were transformed, by
the methods described in Examples 10 and 11, with
pAAEGII-1 which had been digested with HindiSl and
; coRI and trans.formants able to grow on acetamide were
selected. Subsequently, DNA was extracted from stable
transformants, digested with Ps I, subjected to agarose
gel.electrophoresis and blotted onto a membrane filter.
The filter was hybridized with radiolabelled pA.4LEGII-1.
Homologous integration of the HindIII-EcoRI fragment
from pAAEGII-1, which contained eg13 flanking regions
CA 02133436 2003-08-08
WO 93/20208 PCT/US93/03251
- 43 -
and amdS, at the genomic eal3 locus in a transformant
lead to the 4 kb genomic Ps I fragment containing the
e 3 gene being replaced by smaller Psti fragments
including two which would be approximately 1.0 and 2.8
kb in length. This pattern of hybridization was
observed for one transformant which was designated
strain mEG-1. This strain has deletions in both the
EGI and EGII encoding genes and consequently is unable
to produce either of these proteins.
The methods described in Examples 7-17 and in
WO 92/17574 may
be used to obtain T. reesei transformants which are
unable to produce any or all of the following cellulase
components; EG I, EG II, CBHI and CBHZI, and the
xylanase components. Additionally, the methods
described may be used to obtain aT. reesei
transformant which overexpresses the EG III cellulase
component.
While the invention has been described in terms of
various preferred embodiments, the skilled artisan will
appreciate that various modifications, substitutions
omissions and changes may be made without departing
from the spirit and scope thereof. Accordingly, it is
intended that the scope of the present invention be
limited solely by the scope of the following claims,
including equivalents thereof.
